Tucker Asset Management’s GSK GSK Stock Holding History

Tucker Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$30.1K	Buy	+613	New	+$28.6K	0.01%	394
2025 Q1	–	Sell	-88	Closed	-$2.98K	–	575
2024 Q4	$2.98K	Buy	88 +17	+24%	+$612	﹤0.01%	1124
2024 Q3	$2.9K	Sell	71 -84	-54%	-$3.44K	﹤0.01%	1079
2024 Q2	$5.97K	Hold	155	–	–	﹤0.01%	994
2024 Q1	$6.64K	Hold	155	–	–	﹤0.01%	990
2023 Q4	$5.74K	Sell	155 -4	-3%	-$144	﹤0.01%	855
2023 Q3	$5.76K	Hold	159	–	–	﹤0.01%	791
2023 Q2	$5.67K	Hold	159	–	–	﹤0.01%	650
2023 Q1	$5.66K	Hold	159	–	–	﹤0.01%	677
2022 Q4	$5.59K	Hold	159	–	–	﹤0.01%	427
2022 Q3	$5.27K	Buy	159 +75	+89%	+$2.84K	﹤0.01%	420
2022 Q2	$4.57K	Buy	+84	New	+$4.64K	﹤0.01%	351
2021 Q3	–	Sell	-134	Closed	-$6.69K	–	391
2021 Q2	$6.69K	Buy	+134	New	+$6.44K	﹤0.01%	207
2021 Q1	–	Sell	-134	Closed	-$6.18K	–	358
2020 Q4	$6.18K	Buy	+134	New	+$6.16K	﹤0.01%	224

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tucker Asset Management's GSK Position: Q4 2025 in Review

Tucker Asset Management opened a new position in GSK (GSK) in Q4 2025: 613 shares worth $30.1K. The stake represents 0.01% of the portfolio and ranks #394 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in GSK as recently as Q4 2024.

Tucker Asset Management first reported a position in GSK in Q4 2020 and has held it in 14 quarters since. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Tucker Asset Management held 613 shares of GSK worth $30.1K as of Q4 2025.
GSK was a new Tucker Asset Management position in Q4 2025.
GSK made up 0.01% of Tucker Asset Management's portfolio in Q4 2025, its #394 holding.
Tucker Asset Management first reported a position in GSK in Q4 2020 and has held it in 14 quarters since.
995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.